ADMA Biologics (NASDAQ:ADMA – Get Free Report) announced its earnings results on Wednesday. ADMA Biologics had a net margin of 32.43% and a return on equity of 39.98%. ADMA Biologics Stock PerformanceNASDAQ:ADMA traded up $0.35 during mid-day trading on Wednesday, hitting $9.26. ADMA Biologics has a 12 month low of $7.21 and a 12 month high of $20.46. Earnings To Watch: ADMA Biologics Inc Q2 2026An earnings preview highlighted potential valuation upside, with GF Value estimating substantial appreciation if ADMA’s operating performance meets expectations.